PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients
Abstract IONIS‐FXIRX (BAY2306001) is an antisense oligonucleotide that inhibits the synthesis of coagulation factor XI (FXI) and has been investigated in healthy volunteers and patients with end‐stage renal disease (ESRD). FXI‐LICA (BAY2976217) shares the same RNA sequence as IONIS‐FXIRX but contain...
Saved in:
Main Authors: | Stefan Willmann (Author), Eleonora Marostica (Author), Nelleke Snelder (Author), Alexander Solms (Author), Markus Jensen (Author), Maximilian Lobmeyer (Author), Anthonie W. A. Lensing (Author), Claudette Bethune (Author), Erin Morgan (Author), Rosie Z. Yu (Author), Yanfeng Wang (Author), Shiangtung W. Jung (Author), Richard Geary (Author), Sanjay Bhanot (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition
by: Hisham A. Badreldin, et al.
Published: (2024) -
"Familial Multiple Coagulation Factor Deficiencies of FXI and FXII in an Asymptomatic Saudi Woman"
by: Rehab Y. Al-Ansari MBBS, et al.
Published: (2023) -
Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024) -
Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013) -
Predictive Dose-Based Estimation of Systemic Exposure Multiples in Mouse and Monkey Relative to Human for Antisense Oligonucleotides With 2'-O-(2-Methoxyethyl) Modifications
by: Rosie Z Yu, et al.
Published: (2015)